Z-1778-2017 Class II Terminated
FDA device recall Z-1778-2017 was initiated by Merge Healthcare, Inc. on Apr 4, 2016 and is designated Class II. Reason for recall: Use of the software may show an incorrect value to the user when viewing the Fractional Flow Reserve (FFR) results during recording. The recall status is terminated (terminated Feb 21, 2019). Affected quantity: 24 sites potentially have the affected versions.
Recall details
- Product Type
- Devices
- Report Date
- Apr 19, 2017
- Initiation Date
- Apr 4, 2016
- Termination Date
- Feb 21, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24 sites potentially have the affected versions
Product description
Merge Hemo software. The firm name on the labeling is Merge Healthcare, Hartland, WI. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure
Reason for recall
Use of the software may show an incorrect value to the user when viewing the Fractional Flow Reserve (FFR) results during recording.
Distribution pattern
Nationwide Distribution including AZ, CA, CO, FL, GA, KS, LA, MI, MO, OH, OK, TN, TX, VA, WA, WI, and WV.
Code information
Versions 9.10.0, 9.20.0, 9.20.1, 9.20.2, 9.30.3, and 9.40.0.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1778-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026